[Answered] Infectious diseases develop resistance to ________ when used improperly. A) antibiotics B) ...

This topic contains a solution. Click here to go to the answer

Author Question: Infectious diseases develop resistance to ________ when used improperly. A) antibiotics B) ... (Read 65 times)

P68T

Hero Member
Posts: 509

on: Jul 14, 2018

Infectious diseases develop resistance to ________ when used improperly.

A) antibiotics
B) people
C) infants
D) degeneration
E) DDT

Question 2

Which stage of the epidemiological transition is known as the stage of reemergent infectious diseases?

A) Stage 1
B) Stage 2
C) Stage 3
D) Stage 4
E) Stage 5

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

Sarahjh

Sr. Member
Posts: 370

Reply #1 on: Jul 14, 2018

Answer to Question 1

Answer: A

Answer to Question 2

Answer: E

P68T

Member
Posts: 509

Reply 2 on: Jul 14, 2018

TYSM

Liamb2179

Member
Posts: 365

Reply 3 on: Yesterday

Wow, this really help

« previous next »

Did you know?

It is widely believed that giving a daily oral dose of aspirin to heart attack patients improves their chances of survival because the aspirin blocks the formation of new blood clots.

Did you know?

On average, someone in the United States has a stroke about every 40 seconds. This is about 795,000 people per year.

Did you know?

Pink eye is a term that refers to conjunctivitis, which is inflammation of the thin, clear membrane (conjunctiva) over the white part of the eye (sclera). It may be triggered by a virus, bacteria, or foreign body in the eye. Antibiotic eye drops alleviate bacterial conjunctivitis, and antihistamine allergy pills or eye drops help control allergic conjunctivitis symptoms.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.